Identifying Molecular Phenotype of Normal and Asthmatic Bronchial Smooth Muscle
Identifying Molecular Phenotype of Normal and Asthmatic Bronchial Smooth Muscle
批准号:
8258163
负责人:
Xingbin Ai
金额:
$24.54万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2013-12-31
关键词:
AddressAgonistAsthmaBioinformaticsBiological AssayBreathingCell CountCell SizeCellsChronic Airflow ObstructionClinicalComputer SimulationComputer softwareDataDiseaseDsRedFlow CytometryFoundationsFunctional RNAFutureGene ExpressionGenesGeneticGoalsGreen Fluorescent ProteinsIn Situ HybridizationIndividualKnowledgeLogicLuciferasesLungMediatingMessenger RNAMethodologyMicroRNAsMolecularMusMusclePathogenesisPathway AnalysisPathway interactionsPatientsPatternPhenotypePhysiologicalPopulationProcessPropertyProtein FamilyRNARelative (related person)RestReverse Transcriptase Polymerase Chain ReactionRoleShortness of BreathSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesSpecificitySteroidsStudentsSymptomsTestingTimeTransfectionTransgenic MiceTranslational RepressionTubeVascular Smooth MuscleWheezingWorkairway remodelingbaseeffective therapymRNA Expressionmeetingsmolecular phenotypered fluorescent proteintherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asthma is a common disease with several effective treatments, including inhaled steroids and ¿-agonists. Despite this, a small subpopulation of patients has a severe unrelenting course associated with airway remodeling. A central feature of airway remodeling is alteration in bronchial smooth muscle (BSM) phenotype, which is classically characterized by expansion of cell number and size, and increased hyper- reactivity to specific and non-specific agonists. While fundamental to asthma pathogenesis and its clinical manifestations, a lack of knowledge regarding the basis for a deranged BSM phenotype is an ongoing, unresolved, issue in the field. This is manifested by the paucity of information regarding the molecular signals underlying bronchial hyper-reactivity and by the lack of treatments directed specifically at reversing the asthmatic BSM phenotype. One major contributing factor to this state-of-affairs is the lack of tools/methodologies that support the high fidelity isolation of pure BSM cells from asthmatic lungs for analysis. To overcome this, we developed a unique transgenic mouse in which BSM singly express a green fluorescent protein (hrGFP) whereas vascular smooth muscle express green (hrGFP) and red fluorescent proteins (dsRed); thereby providing for the first time a reliable methodology for separating each of these two smooth muscle cell populations from one another, and from other lung cells using flow cytometry. Using this unique mouse, our plan is to perform comprehensive mRNA and miRNA profiling of BSM RNA to test the following broad based hypothesis: 1) BSM express a distinct genetic signature and 2) alterations in this signature mediate asthmatic BSM phenotypes. Our plan is to use the profiling data to generate lists of complete and differentially expressed mRNAs and miRNAs in normal and asthmatic BSM. Relationships between deregulated miRNAs, mRNA expression, and the identity of active signaling pathways in asthmatic BSM will be examined by bioinformatic and functional studies. At the end of this work, we will have initiated a process to fill a marked knowledge void in the asthma field and will have established a foundation for a variety of future studies.
PUBLIC HEALTH RELEVANCE: Asthma involves changes in the function and properties of the muscle that surrounds the bronchial tube. While central to the many of the symptoms associated with asthma including wheezing and shortness of breath, the molecular signals that cause changes in bronchial muscle are poorly understood. The objective of this proposal is to use several unique tools and methodologies that we developed to identify key molecular signals that underlay the change in bronchial smooth muscle in asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 imprints airway basal cells to impair epithelium regeneration
-
批准号:10738549
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2023
-
负责人:Xingbin Ai
-
依托单位:
Age-related mechanisms of T helper 2 memory in the early lung
-
批准号:10316809
-
项目类别:
-
资助金额:$58.82万
-
财政年份:2021
-
负责人:Xingbin Ai
-
依托单位:
Age-related mechanisms of T helper 2 memory in the early lung
-
批准号:10447694
-
项目类别:
-
资助金额:$54.34万
-
财政年份:2021
-
负责人:Xingbin Ai
-
依托单位:
Age-related mechanisms of T helper 2 memory in the early lung
-
批准号:10653092
-
项目类别:
-
资助金额:$53.95万
-
财政年份:2021
-
负责人:Xingbin Ai
-
依托单位:
Development of PNEC innervation and neuroplasticity after early life insult
-
批准号:9310524
-
项目类别:
-
资助金额:$44.91万
-
财政年份:2017
-
负责人:Xingbin Ai
-
依托单位:
Development of PNEC innervation and neuroplasticity after early life insult
-
批准号:10089028
-
项目类别:
-
资助金额:$42.77万
-
财政年份:2017
-
负责人:Xingbin Ai
-
依托单位:
Identification of Sulfs as therapeutic targets for the treatment of age-impaired skeletal muscle regeneration
-
批准号:8918172
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2014
-
负责人:Xingbin Ai
-
依托单位:
The Fetal Lung Mesothelial Differentiation Program
-
批准号:8462105
-
项目类别:
-
资助金额:$52.6万
-
财政年份:2013
-
负责人:Xingbin Ai
-
依托单位:
The Fetal Lung Mesothelial Differentiation Program
-
批准号:8854132
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2013
-
负责人:Xingbin Ai
-
依托单位:
The Fetal Lung Mesothelial Differentiation Program
-
批准号:9069951
-
项目类别:
-
资助金额:$54.14万
-
财政年份:2013
-
负责人:Xingbin Ai
-
依托单位:
The Fetal Lung Mesothelial Differentiation Program
-
批准号:8712548
-
项目类别:
-
资助金额:$61.15万
-
财政年份:2013
-
负责人:Xingbin Ai
-
依托单位:
Identifying Molecular Phenotype of Normal and Asthmatic Bronchial Smooth Muscle
-
批准号:8403835
-
项目类别:
-
资助金额:$19.48万
-
财政年份:2012
-
负责人:Xingbin Ai
-
依托单位:
HEPARAN SULFATE BIOSYNTHETIC FEEDBACKS AND EXTRACELLULAR SULFATASE EXPRESSION
-
批准号:8365568
-
项目类别:
-
资助金额:$1.23万
-
财政年份:2011
-
负责人:Xingbin Ai
-
依托单位:
Sulfs as therapeutic targets in age-impaired skeletal muscle regeneration
-
批准号:8220748
-
项目类别:
-
资助金额:$32.24万
-
财政年份:2010
-
负责人:Xingbin Ai
-
依托单位:
Identification of Sulfs as therapeutic targets for the treatment of age-impaired
-
批准号:7765856
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2010
-
负责人:Xingbin Ai
-
依托单位:
Identification of Sulfs as therapeutic targets for the treatment of age-impaired
-
批准号:8036993
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2010
-
负责人:Xingbin Ai
-
依托单位:
HEPARAN SULFATE BIOSYNTHETIC FEEDBACKS AND EXTRACELLULAR SULFATASE EXPRESSION
-
批准号:8170942
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2010
-
负责人:Xingbin Ai
-
依托单位:
Identification of Sulfs as therapeutic targets for the treatment of age-impaired
-
批准号:8423334
-
项目类别:
-
资助金额:$30.48万
-
财政年份:2010
-
负责人:Xingbin Ai
-
依托单位:
POST-BIOSYNTHETIC MODIFICATION OF HEPARAN SULFATE BY REACTIVE NITROGEN SPECIES
-
批准号:8170901
-
项目类别:
-
资助金额:$2.43万
-
财政年份:2010
-
负责人:Xingbin Ai
-
依托单位:
The signaling role of Qsulf in embryonic neural tube
-
批准号:6753545
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2002
-
负责人:Xingbin Ai
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: